allogeneic teazeled-receptor-activated human white blood cell therapy (Second Life Therapeutics)

N/A

Report date: 2025/06/11 10:16:19

Base Information

Drug Nameallogeneic teazeled-receptor-activated human white blood cell therapy (Second Life Therapeutics)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy
Mechanisms of ActionCell replacements
TargetsNot applicable
Therapy Area/IndicationsPancreatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSecond Life Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesSecond Life Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsPancreatic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A